Cargando...
Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage
Dabigatran etexilate mesylate is a direct thrombin inhibitor used for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Dabigatran belongs to a new generation of oral agents for anticoagulation – the direct oral anticoagulants (DOACs). The DOACs als...
Guardado en:
| Publicado en: | Clin Pract Cases Emerg Med |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5965212/ https://ncbi.nlm.nih.gov/pubmed/29849330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5811/cpcem.2017.6.34356 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|